Last Price
277.02
Today's Change
+1.52 (0.55%)
Day's Change
276.45 - 278.05
Trading Volume
119,900
Overview
Market Cap
133 Billion
Shares Outstanding
483 Million
Avg Volume
691,352
Avg Price (50 Days)
280.20
Avg Price (200 Days)
271.29
PE Ratio
35.47
EPS
7.81
Earnings Announcement
13-Feb-2024
Previous Close
275.50
Open
277.50
Day's Range
276.45 - 278.05
Year Range
228.65 - 312.99
Trading Volume
120,074
Price Change Highlight
1 Day Change
0.55%
5 Day Change
0.77%
1 Month Change
-1.08%
3 Month Change
-8.26%
6 Month Change
11.60%
Ytd Change
-3.91%
1 Year Change
-8.05%
3 Year Change
0.05%
5 Year Change
39.28%
10 Year Change
297.80%
Max Change
33397.58%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
Australian Jobs Surprisingly Fall, Giving RBA Scope for Patience
2
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
